Khurana, S., Verma, N., Yewdell, J. W., Hilbert, A. K., Castellino, F., Lattanzi, M., . . . Golding, H. (2011). MF59 Adjuvant Enhances Diversity and Affinity of Antibody-Mediated Immune Response to Pandemic Influenza Vaccines.
Citação norma ChicagoKhurana, Surender, Nitin Verma, Jonathan W. Yewdell, Anne Katrin Hilbert, Flora Castellino, Maria Lattanzi, Giuseppe Del Giudice, Rino Rappuoli, and Hana Golding. MF59 Adjuvant Enhances Diversity and Affinity of Antibody-Mediated Immune Response to Pandemic Influenza Vaccines. 2011.
Citação norma MLAKhurana, Surender, et al. MF59 Adjuvant Enhances Diversity and Affinity of Antibody-Mediated Immune Response to Pandemic Influenza Vaccines. 2011.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.